(Q53178014)

12 May 2018

title

Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan. (English)

1 reference

12 May 2018

1 reference

Kuniaki Itoh

1

1 reference

12 May 2018

Tomohiro Kinoshita

2

1 reference

12 May 2018

Takashi Watanabe

3

1 reference

12 May 2018

Kenichi Yoshimura

4

1 reference

12 May 2018

Rumiko Okamoto

5

1 reference

12 May 2018

Takaaki Chou

6

1 reference

12 May 2018

Michinori Ogura

7

1 reference

12 May 2018

Masami Hirano

8

1 reference

12 May 2018

Hideki Asaoku

9

1 reference

12 May 2018

Mitsutoshi Kurosawa

10

1 reference

12 May 2018

Yoshiharu Maeda

11

1 reference

12 May 2018

Ken Omachi

12

1 reference

12 May 2018

Yukiyoshi Moriuchi

13

1 reference

12 May 2018

Masaharu Kasai

14

1 reference

12 May 2018

Kazunori Ohnishi

15

1 reference

12 May 2018

Nobuyuki Takayama

16

1 reference

12 May 2018

Yasuo Morishima

17

1 reference

12 May 2018

Kensei Tobinai

18

1 reference

12 May 2018

Harumi Kaba

19

1 reference

12 May 2018

Seiichiro Yamamoto

20

1 reference

12 May 2018

Haruhiko Fukuda

21

1 reference

12 May 2018

Masahiro Kikuchi

22

1 reference

12 May 2018

Tadashi Yoshino

23

1 reference

12 May 2018

Yoshihiro Matsuno

24

1 reference

12 May 2018

Tomomitsu Hotta

25

1 reference

12 May 2018

Masanori Shimoyama

26

1 reference

12 May 2018

publication date

3 March 2010

1 reference

12 May 2018

International Journal of Hematology

published in

1 reference

12 May 2018

volume

91

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

446-455

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s12185-010-0533-9

exact match

0 references

cites work

Prognostic factors in Hodgkin's lymphoma

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-010-0533-9

Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-010-0533-9

Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-010-0533-9

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

12 December 2020

Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry

1 reference

12 December 2020

A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002.

1 reference

12 December 2020

Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma

1 reference

12 December 2020

Hodgkin lymphoma: the follow-up of long-term survivors

1 reference

12 December 2020

Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality

1 reference

12 December 2020

Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease

1 reference

12 December 2020

Hodgkin disease survival in Europe and the U.S

1 reference

12 December 2020

The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma

1 reference

12 December 2020

Prognostic role of serum beta 2-microglobulin in Hodgkin's disease

1 reference

12 December 2020

Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group

1 reference

12 December 2020

Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites

1 reference

12 December 2020

Prognostic Significance of T-Cell or Cytotoxic Molecules Phenotype in Classical Hodgkin’s Lymphoma: A Clinicopathologic Study

1 reference

12 December 2020

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials

1 reference

12 December 2020

The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists

1 reference

12 December 2020

A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels

1 reference

12 December 2020

Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science

1 reference

12 December 2020

Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 Patients

1 reference

12 December 2020

What do we mean by validating a prognostic model?

1 reference

12 December 2020

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease

1 reference

12 December 2020

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

12 December 2020

Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy

1 reference

12 December 2020

Treatment of Hodgkin lymphoma: the past, present, and future.

1 reference

12 December 2020

Prognosis and prognostic research: Developing a prognostic model

1 reference

12 December 2020

Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future

1 reference

12 December 2020

10.1007/S12185-010-0533-9

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

20198461

1 reference

12 May 2018